David Kim, PhD, to serve as Program Director of the CEA Registry

By Anna Legassie, Manager, Development and Communications

The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center is pleased to announce that Assistant Professor, David Kim, PhD, will serve as Program Director for the Cost-Effectiveness Analysis (CEA) Registry providing intellectual leadership, generating ideas for new analyses, and collaborating with researchers at other institutions using the Registry’s data to advance the field.

The CEA Registry contains information on more than 20,000 standardized cost-effectiveness ratios on health interventions published through 2018 in the peer-reviewed literature. By cataloguing studies that estimate costs and health benefits for a wide range of interventions, the Registry helps to identify promising opportunities to better invest the nation’s health care resources.

Dr. Kim, who joined CEVR in 2016, conducts research on the use of clinical and economic evidence in health policy decision making, as well as economic evaluations of health/nutrition policy and medical technology, and on value of information analysis. In his new position, David will continue these efforts, while directing new initiatives using Registry data to analyze the benefits, risks and costs of strategies to improve health and health care.

In 2020, the CEA Registry will celebrate its 20th anniversary.  With this milestone will come major advances for the database including a full redesign and renovation of the dashboard tool, continued efforts to improve the quality and standardization of the data, and a renewed focus on improving the user experience.

“I’m thrilled that David will be heading our CEA Registry efforts going forward. His experience in the field and his work with the Second Panel on Cost-Effectiveness in Health and Medicine will serve him well as he takes on this effort,” says CEVR Director, Peter Neumann, ScD, “I also want to thank Tara Lavelle, PhD, for her excellent work these past few years in updating and advancing the Registry.”

Founded by Peter Neumann, ScD, and Joshua Cohen, PhD, CEVR Deputy Director and Chief Science Officer, the CEA Registry is a comprehensive, regularly-updated database of over 8,000 cost-utility analyses on a wide variety of diseases and treatments. For access to the data or CEVR sponsorship, please contact Julie Crowe

David Kim, PhD, to serve as Program Director of the CEA Registry

More News Articles